Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00222131Phase 2Completed
Phase 2, randomised, double-blind trial in dyspepsia comparing Placebo with Esomeprazole (2 arms). Primary endpoint: Percentage of Participants With Satisfactory Relief of Non-ulcer Dyspepsia Symptoms at 8 weeks. Started Oct 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00222131.